Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Medical checks help find out if symptoms come from weight loss changes or other health issues
Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously, with Phase 2 trials using once-weekly subcutaneous doses of 1 mg to 12 mg
Wegovy has the cardiovascular benefit label the NICE April 2026 cardiovascular indication (BMI 27+ with established CVD) applies to semaglutide (Wegovy), not tirzepatide (Mounjaro)
Zepbound (tirzepatide) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition
Additionally, GHK-Cu increases the expression of lysyl oxidase, the enzyme responsible for cross-linking collagen and elastin fibers, thereby reinforcing the three-dimensional architecture of the extracellular matrix
It belongs to the same broad family of medicines as Wegovy and Mounjaro, but it works on more pathways than either of them
US$ 27.08
US$ 26.15
US$ 21.86
US$ 22.93
US$ 27.52
US$ 26.97
